← Leaderboards
Kevin A Snook
Trs Technologies, Inc.
$2,470,676
Attributed
$2,470,676
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $835.2K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,470,676 · 6
By mechanism
R43$1,596,403 · 4
R44$742,881 · 1
N01$131,392 · 1
Top collaborators
No co-investigators on record.
Most similar at Trs Technologies, Inc.
Same institution · by research overlap
- Xiaoning Jiang$5,628,202
Others in their field
Top investigators on “Commercialization”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- George Asseng · Dhs-Us Army Medical Research$208,178,288
- Joel A Lipkin · Four Points Technology, Llc$185,041,546
- Gary Craft · Ch2m Hill Constructors, Inc$155,196,016
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
CommercializationUnited States National Institutes Of HealthDevicesTechnologyNervous System DisorderModalityPerformanceFundingBrainInnovationPreclinical StudyTranslationsVibrationPublic HealthDiagnosisEnteral FeedingTransducersSmall Business Innovation Research GrantBlood SpecimenAccelerationDesignRodentLegal PatentAcoustics
Grant awards (13)
ENDOVASCULAR HORIZONS TESTING TO5. RESEARCH AND DEVELOPMENT FOR BIOCOMPATIBILITY TESTING, ANIMAL STUDIES, AND STERILIZATION TESTING IN THE BLUEPRINT MEDTECH (BPMT) INITIATIVE. 08/18/2025 - 02/17/2026.$65,696
N01 · FY2025 · DA · contact PI
TASK ORDER 04: BIOCOMPATIBILITY TESTING FOR RHAEOS. PERIOD OF PERFORMANCE: 7/14/2025 - 1/13/2026$32,848
N01 · FY2025 · DA · contact PI
BIOCOMPATIBILITY TESTING FOR NEURASTASIS. RESEARCH AND DEVELOPMENT FOR BIOCOMPATIBILITY TESTING, ANIMAL STUDIES, AND STERILIZATION TESTING IN THE BLUEPRINT MEDTECH (BPMT) INITIATIVE. 8/18/25-02/17/26$32,848
N01 · FY2025 · DA · contact PI
Development of a Miniaturized Wearable Ultrasonic Beam-forming Device for Localized Targeting of Brain Regions in Freely-moving Experimental Subjects$267,728
R43 · FY2023 · NS · contact PI
Diversity Supplement for Development of a Miniaturized Wearable Ultrasonic Beam-forming Device for Localized Targeting of Brain Regions in Freely-moving Experimental Subjects$24,129
R43 · FY2023 · NS · contact PI
Diversity Supplement for Development of a Miniaturized Wearable Ultrasonic Beam-forming Device for Localized Targeting of Brain Regions in Freely-moving Experimental Subjects$24,129
R43 · FY2023 · NS · contact PI
Development of a Miniaturized Wearable Ultrasonic Beam-forming Device for Localized Targeting of Brain Regions in Freely-moving Experimental Subjects$450,304
R43 · FY2022 · NS · contact PI
Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment$384,932
R43 · FY2022 · AA · contact PI
Innovation Corp Program and Commercialization Planning for 'Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone'$49,999
R43 · FY2018 · CA · contact PI
Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone$295,205
R43 · FY2017 · CA · contact PI
Micromachined Single Crystal HF Arrays for Interventional Cardiology Ultrasound$357,316
R44 · FY2008 · EB · contact PI
Micromachined Single Crystal HF Arrays for Interventional Cardiology Ultrasound$385,565
R44 · FY2007 · EB · contact PI
Novel Micromachined Single Crystal Patterning for Wideband Dermatology Transducer$99,977
R43 · FY2006 · CA · contact PI